ENTX
ENTX
NASDAQ · Biotechnology

Entera Bio Ltd

$1.04
-0.13 (-11.11%)
As of Feb 8, 2:18 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,089.4% upside
Low Target $34.30
Average Target $43.57
High Target $49.66
Current Price $1.04
Current
$1.04
Target
$43.57
$34.30 $43.57 avg $49.66
Scenario Analysis
Bear Case
$34.30
3,198.1%
Low target
Base Case
$43.57
+4,089.4%
Avg target
Bull Case
$49.66
+4,675.0%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$43.61
-97.6% from high
52-Week Low
$20.38
+-94.9% from low
Target vs 52W High
$43.57
-0.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%